Safety and Efficacy of Zemplar Capsule in Reducing Serum iPTH Levels in Chronic Kidney Disease Subjects (Three Times Weekly)

PHASE3CompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

February 28, 2002

Conditions
Renal Insufficiency, Chronic
Interventions
DRUG

paricalcitol

Trial Locations (19)

10021

The Rogosin Institute, New York

20852

Biolab Research, LLC, Rockville

32610

University of Florida, Gainesville

33143

Miami Kidney Group, Miami

33614

Genesis Clinical Research Corporation, Tampa

34232

ICSL Clinical Studies, Sarasota

45206

Dialysis Clinic, Inc., Cincinnati

47714

Medisphere Medical Research Center, Evansville

60201

Evanston Northwestern Healthcare, Evanston

70121

Ochsner Clinic Chronic Dialysis, New Orleans

77030

Kidney Associates, Houston

78229

University of Texas Health Science Center, San Antonio

79430

Texas Tech University Health Science Center, Lubbock

85712

Tucson Therapeutic Research Institute, Inc., Tucson

91105

Pasadena

91356

Nephrology Educational Services and Research, Inc., Tarzana

92120

California Institute of Renal Research, San Diego

06708

Phoenix Internal Medicine Associates, Waterbury

Unknown

Wojskowy Instytut Medyczny, Warsaw

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Abbott

INDUSTRY